WFM
HAE icon

Wilmington Funds Management’s Haemonetics HAE Stock Holding History

Wilmington Funds Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,423
Closed -$437K – 774
2014
Q1 		$437K Sell
13,423
-2,906
-18% -$111K 0.05% 400
2013
Q4 		$688K Buy
16,329
+829
+5% +$34.1K 0.07% 309
2013
Q3 		$618K Hold
15,500
– – 0.06% 321
2013
Q2 		$641K Buy
+15,500
New +$628K 0.06% 316

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Wilmington Funds Management's HAE Position: Q2 2014 in Review

Wilmington Funds Management sold out of Haemonetics (HAE) in Q2 2014, closing a stake of 13,423 shares — an estimated $437K sold.

Wilmington Funds Management first reported a position in HAE in Q2 2013 and held it in 4 quarters. The position peaked at $688K in Q4 2013. 175 funds tracked by Wall St. Rank hold HAE as of Q2 2014.

  • Wilmington Funds Management reported no remaining Haemonetics position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 13,423 Haemonetics shares in Q2 2014, an estimated $437K.
  • Wilmington Funds Management first reported a position in Haemonetics in Q2 2013 and held it in 4 quarters.
  • Wilmington Funds Management's Haemonetics position peaked at $688K in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Haemonetics as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.